loadpatents
Patent applications and USPTO patent grants for Popovici-Muller; Janeta.The latest application filed is for "heterobicyclic inhibitors of mat2a and methods of use for treating cancer".
Patent | Date |
---|---|
Therapeutically active compounds and their methods of use Grant 11,021,515 - Lemieux , et al. June 1, 2 | 2021-06-01 |
Heterobicyclic Inhibitors Of Mat2a And Methods Of Use For Treating Cancer App 20210115045 - KONTEATIS; Zenon D. ;   et al. | 2021-04-22 |
Therapeutically active compounds and their methods of use Grant 10,946,023 - Konteatis , et al. March 16, 2 | 2021-03-16 |
Therapeutically Active Compounds And Their Methods Of Use App 20210024575 - Popovici-Muller; Janeta ;   et al. | 2021-01-28 |
Therapeutically Active Compounds And Their Methods Of Use App 20200339626 - Lemieux; Rene M. ;   et al. | 2020-10-29 |
Therapeutically active compounds and their methods of use Grant 10,717,764 - Popovici-Muller , et al. | 2020-07-21 |
Compounds and their methods of use Grant 10,689,375 - Lemieux , et al. | 2020-06-23 |
Therapeutically active compounds and their methods of use Grant 10,689,414 - Lemieux , et al. | 2020-06-23 |
Therapeutically active compositions and their methods of use Grant 10,640,534 - Popovici-Muller , et al. | 2020-05-05 |
Therapeutically Active Compounds And Their Methods Of Use App 20200079755 - Cianchetta; Giovanni ;   et al. | 2020-03-12 |
Therapeutically Active Compounds And Their Methods Of Use App 20190315802 - Popovici-Muller; Janeta ;   et al. | 2019-10-17 |
Glutaminase inhibitors and method of use Grant 10,414,740 - Lemieux , et al. Sept | 2019-09-17 |
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer Grant 10,376,510 - Konteatis , et al. A | 2019-08-13 |
Therapeutically active compounds and their methods of use Grant 10,294,215 - Cianchetta , et al. | 2019-05-21 |
Therapeutically Active Compounds And Their Methods Of Use App 20190117661 - Konteatis; Zenon D. ;   et al. | 2019-04-25 |
Compounds And Their Methods Of Use App 20190084976 - Lemieux; Rene M. ;   et al. | 2019-03-21 |
Therapeutic compounds and compositions Grant 10,202,339 - Popovici-Muller , et al. Feb | 2019-02-12 |
Therapeutically Active Compounds And Their Methods Of Use App 20190023737 - Lemieux; Rene M. ;   et al. | 2019-01-24 |
Therapeutically active compounds and their methods of use Grant 10,172,864 - Konteatis , et al. J | 2019-01-08 |
Glutaminase Inhibitors And Method Of Use App 20180370930 - Lemieux; Rene M. ;   et al. | 2018-12-27 |
Compounds and their methods of use Grant 10,087,172 - Lemieux , et al. October 2, 2 | 2018-10-02 |
Therapeutically active compounds and their methods of use Grant 10,028,961 - Konteatis , et al. July 24, 2 | 2018-07-24 |
Therapeutically Active Compositions And Their Methods Of Use App 20180194802 - Popovici-Muller; Janeta ;   et al. | 2018-07-12 |
Glutaminase inhibitors and method of use Grant 10,011,574 - Lemieux , et al. July 3, 2 | 2018-07-03 |
Therapeutically active compositions and their methods of use Grant 9,856,279 - Cao , et al. January 2, 2 | 2018-01-02 |
Therapeutically active compositions and their methods of use Grant 9,850,277 - Popovici-Muller , et al. December 26, 2 | 2017-12-26 |
Therapeutically Active Compounds And Their Methods Of Use App 20170298045 - Cianchetta; Giovanni ;   et al. | 2017-10-19 |
Therapeutically active compounds and their methods of use Grant 9,732,062 - Cianchetta , et al. August 15, 2 | 2017-08-15 |
Therapeutically Active Compositions And Their Methods Of Use App 20170210749 - Cao; Sheldon ;   et al. | 2017-07-27 |
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer Grant 9,662,327 - Cao , et al. May 30, 2 | 2017-05-30 |
Therapeutically active compounds and their methods of use Grant 9,656,999 - Cianchetta , et al. May 23, 2 | 2017-05-23 |
Therapeutically Active Compounds And Their Methods Of Use App 20170107194 - Konteatis; Zenon D. ;   et al. | 2017-04-20 |
Therapeutically Active Compounds And Their Methods Of Use App 20170057994 - Lemieux; Rene M. ;   et al. | 2017-03-02 |
Therapeutically active compounds and their methods of use Grant 9,579,324 - Konteatis , et al. February 28, 2 | 2017-02-28 |
Therapeutically Active Compounds And Their Methods Of Use App 20170044139 - Cianchetta; Giovanni ;   et al. | 2017-02-16 |
Therapeutically Active Compositions And Their Methods Of Use App 20170015703 - Popovici-Muller; Janeta ;   et al. | 2017-01-19 |
Therapeutically active compositions and their methods of use Grant 9,512,107 - Cianchetta , et al. December 6, 2 | 2016-12-06 |
Therapeutically Active Compositions And Their Methods Of Use App 20160318903 - Cianchetta; Giovanni ;   et al. | 2016-11-03 |
Therapeutically active compositions and their methods of use Grant 9,474,779 - Lemieux , et al. October 25, 2 | 2016-10-25 |
Therapeutically Active Compounds And Their Methods Of Use App 20160304556 - Popovici-Muller; Janeta ;   et al. | 2016-10-20 |
Therapeutic compounds and compositions and their use as PKM2 modulators Grant 9,458,132 - Cianchetta , et al. October 4, 2 | 2016-10-04 |
Therapeutically Active Compositions And Their Methods Of Use App 20160264621 - Popovici-Muller; Janeta ;   et al. | 2016-09-15 |
Therapeutically Active Compositions And Their Methods Of Use App 20160229876 - Cao; Sheldon ;   et al. | 2016-08-11 |
Therapeutically Active Compounds And Their Methods Of Use App 20160220572 - Konteatis; Zenon D. ;   et al. | 2016-08-04 |
Therapeutic compounds and compositions Grant 9,365,545 - Cianchetta , et al. June 14, 2 | 2016-06-14 |
2,4- Or 4,6-diaminopyrimidine Compounds As Idh2 Mutants Inhibitors For The Treatment Of Cancer App 20160158230 - Konteatis; Zenon D. ;   et al. | 2016-06-09 |
Therapeutically Active Compositions And Their Methods Of Use App 20160130298 - Lemieux; Rene M. ;   et al. | 2016-05-12 |
Compounds and their methods of use Grant 9,303,002 - Lemieux , et al. April 5, 2 | 2016-04-05 |
Therapeutic Compounds And Compositions App 20160046579 - Cianchetta; Giovanni ;   et al. | 2016-02-18 |
Therapeutic Compounds And Compositions App 20150336931 - Cianchetta; Giovanni ;   et al. | 2015-11-26 |
Therapeutic Compounds And Compositions And Their Use As Pkm2 Modulators App 20150307473 - Cianchetta; Giovanni ;   et al. | 2015-10-29 |
Glutamase Inhibitors And Method Of Use App 20150299152 - Lemieux; Rene M. ;   et al. | 2015-10-22 |
Therapeutic Compounds And Compositions App 20150299115 - Popovici-Muller; Janeta ;   et al. | 2015-10-22 |
Compounds And Their Methods Of Use App 20150291576 - Lemieux; Rene M. ;   et al. | 2015-10-15 |
Therapeutic compounds and compositions Grant 9,108,921 - Cianchetta , et al. August 18, 2 | 2015-08-18 |
Compounds and their methods of use Grant 9,029,531 - Lemieux , et al. May 12, 2 | 2015-05-12 |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors Grant 8,993,535 - Popovici-Muller , et al. March 31, 2 | 2015-03-31 |
Therapeutically Active Compounds And Their Methods Of Use App 20150087600 - Popovici-Muller; Janeta ;   et al. | 2015-03-26 |
Therapeutically Active Compounds And Their Methods Of Use App 20150031627 - Lemieux; Rene M. ;   et al. | 2015-01-29 |
Therapeutically Active Compounds And Their Methods Of Use App 20150018328 - Konteatis; Zenon D. ;   et al. | 2015-01-15 |
Therapeutic Compounds And Compositions App 20140288081 - Cianchetta; Giovanni ;   et al. | 2014-09-25 |
Therapeutically Active Compositions And Their Methods Of Use App 20140213580 - Cao; Sheldon ;   et al. | 2014-07-31 |
Therapeutically Active Compositions And Their Methods Of Use App 20140206673 - Cao; Sheldon ;   et al. | 2014-07-24 |
Compounds And Their Methods Of Use App 20140142081 - Lemieux; Rene M. ;   et al. | 2014-05-22 |
Compounds And Their Methods Of Use App 20140142146 - Lemieux; Rene M. ;   et al. | 2014-05-22 |
Compounds for the treatment of inflammatory disorders Grant 8,569,336 - Tong , et al. October 29, 2 | 2013-10-29 |
Compounds for the treatment of inflammatory disorders Grant 8,541,572 - Kozlowski , et al. September 24, 2 | 2013-09-24 |
Therapeutically Active Compounds And Their Methods Of Use App 20130190287 - Cianchetta; Giovanni ;   et al. | 2013-07-25 |
Therapeutically Active Compositions And Their Methods Of Use App 20130190249 - Lemieux; Rene M. ;   et al. | 2013-07-25 |
Therapeutically Active Compositions And Their Methods Of Use App 20130184222 - Popovici-Muller; Janeta ;   et al. | 2013-07-18 |
Modulators Of Cell Cycle Checkpoints And Their Use In Combination With Checkpoint Kinase Inhibitors App 20120184505 - Popovici-Muller; Janeta ;   et al. | 2012-07-19 |
Compounds for the treatment of inflammatory disorders Grant 8,178,553 - Lavey , et al. May 15, 2 | 2012-05-15 |
Compounds For The Treatment Of Inflammatory Disorders App 20120015926 - Tong; Ling ;   et al. | 2012-01-19 |
Compounds For The Treatment Of Inflammatory Disorders App 20120010181 - Kozlowski; Joseph A. ;   et al. | 2012-01-12 |
Compounds for the treatment of inflammatory disorders Grant 7,879,890 - Yu , et al. February 1, 2 | 2011-02-01 |
Compounds for the treatment of inflammatory disorders Grant 7,772,263 - Lavey , et al. August 10, 2 | 2010-08-10 |
Compounds For The Treatment Of Inflammatory Disorders App 20100145048 - Guo; Zhuyan ;   et al. | 2010-06-10 |
Compounds For The Treatment Of Inflammatory Disorders App 20100120838 - Lavey; Brian J. ;   et al. | 2010-05-13 |
Compounds for the treatment of inflammatory disorders Grant 7,687,527 - Yu , et al. March 30, 2 | 2010-03-30 |
Compounds for the treatment of inflammatory disorders Grant 7,683,088 - Lavey , et al. March 23, 2 | 2010-03-23 |
Compounds for the treatment of inflammatory disorders Grant 7,652,020 - Guo , et al. January 26, 2 | 2010-01-26 |
Compounds For The Treatment Of Inflammatory Disorders App 20090170875 - Yu; Wensheng ;   et al. | 2009-07-02 |
Compounds For The Treatment Of Inflammatory Disorders App 20090156586 - Lavey; Brian J. ;   et al. | 2009-06-18 |
Compounds For The Treatment Of Inflammatory Disorders App 20090137586 - Yu; Wensheng ;   et al. | 2009-05-28 |
Compounds for the treatment of inflammatory disorders Grant 7,524,842 - Lavey , et al. April 28, 2 | 2009-04-28 |
High affinity quinoline-based kinase ligands Grant 7,511,063 - Deng , et al. March 31, 2 | 2009-03-31 |
Compounds for the treatment of inflammatory disorders Grant 7,504,424 - Yu , et al. March 17, 2 | 2009-03-17 |
Compounds for the treatment of inflammatory disorders Grant 7,488,745 - Yu , et al. February 10, 2 | 2009-02-10 |
Novel high affinity quinoline-based kinase ligands App 20080045568 - Deng; Yongqi ;   et al. | 2008-02-21 |
Compounds for the treatment of inflammatory disorders App 20070265299 - Lavey; Brian J. ;   et al. | 2007-11-15 |
Compounds for the treatment of inflammatory disorders App 20070219218 - Yu; Wensheng ;   et al. | 2007-09-20 |
Compounds for the treatment of inflammatory disorders App 20070197564 - Lavey; Brian J. ;   et al. | 2007-08-23 |
Compounds for the treatment of inflammatory disorders App 20060276506 - Yu; Wensheng ;   et al. | 2006-12-07 |
Compounds for the treatment of inflammatory disorders App 20060252778 - Guo; Zhuyan ;   et al. | 2006-11-09 |
Pyrazolo[1,5a]pyrimidine compounds as antiviral agents App 20040038993 - Shipps, Gerald W. ;   et al. | 2004-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.